 | • レポートコード：QAF27757 • 出版社/出版日：QYResearch / 2021年3月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のラタノプロスト市場について種類別（ブランド薬品、ジェネリック薬品）、用途別（開放隅角緑内障、閉鎖隅角緑内障）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ラタノプロスト市場の概要 ・世界の主要地域別ラタノプロスト市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のラタノプロスト市場規模2016-2021：種類別（ブランド薬品、ジェネリック薬品） ・世界のラタノプロスト市場予測2012-2027：種類別（ブランド薬品、ジェネリック薬品） ・世界のラタノプロスト市場規模2016-2021：用途別（開放隅角緑内障、閉鎖隅角緑内障） ・世界のラタノプロスト市場予測2012-2027：用途別（開放隅角緑内障、閉鎖隅角緑内障） ・ラタノプロストのアメリカ市場規模と予測2016-2021 ・ラタノプロストのヨーロッパ市場規模と予測2016-2021 ・ラタノプロストの中国市場規模と予測2016-2021 ・ラタノプロストの日本市場規模と予測2016-2021 ・ラタノプロストの東南アジア市場規模と予測2016-2021 ・ラタノプロストのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Mylan、Novartis、Apotex、Teva、Taj Pharma、CR Zizhu） ・ラタノプロストの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ラタノプロストの市場動向・機会・課題 ・調査の結論 |
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Latanoprost is widely used in the treatment of Open-angle Glaucoma and Closed-angle Glaucoma. The most proportion of Latanoprost is Open-angle Glaucoma, and the sales market share in 2016 is about 82%. North America is the largest supplier and Europe is in the second place of production market with market share of 36.5% and 28.9%. On the other hand, North America and Europe are also the top 2 consumption market with market share of 36.3% and 20.5%.
Market Analysis and Insights: Global Latanoprost Market
The global Latanoprost market was valued at US$ 1374.1 in 2020 and will reach US$ 1565.8 million by the end of 2027, growing at a CAGR of 2.2% during 2022-2027.
Global Latanoprost Scope and Market Size
The global Latanoprost market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Latanoprost market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
The Latanoprost market is analysed and market size information is provided by regions (countries). Segment by Application, the Latanoprost market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
1 Latanoprost Market Overview
1.1 Latanoprost Product Scope
1.2 Latanoprost Segment by Type
1.2.1 Global Latanoprost Sales by Type (2016 & 2021 & 2027)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Latanoprost Segment by Application
1.3.1 Global Latanoprost Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Open-angle Glaucoma
1.3.3 Close-angle Glaucoma
1.4 Latanoprost Market Estimates and Forecasts (2016-2027)
1.4.1 Global Latanoprost Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Latanoprost Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Latanoprost Price Trends (2016-2027)
2 Latanoprost Estimates and Forecasts by Region
2.1 Global Latanoprost Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Latanoprost Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Latanoprost Sales Market Share by Region (2016-2021)
2.2.2 Global Latanoprost Revenue Market Share by Region (2016-2021)
2.3 Global Latanoprost Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Latanoprost Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Latanoprost Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Latanoprost Estimates and Projections (2016-2027)
2.4.2 Europe Latanoprost Estimates and Projections (2016-2027)
2.4.3 China Latanoprost Estimates and Projections (2016-2027)
2.4.4 Japan Latanoprost Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Latanoprost Estimates and Projections (2016-2027)
2.4.6 India Latanoprost Estimates and Projections (2016-2027)
3 Global Latanoprost Competition Landscape by Players
3.1 Global Top Latanoprost Players by Sales (2016-2021)
3.2 Global Top Latanoprost Players by Revenue (2016-2021)
3.3 Global Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Latanoprost as of 2020)
3.4 Global Latanoprost Average Price by Company (2016-2021)
3.5 Manufacturers Latanoprost Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Latanoprost Market Size by Type
4.1 Global Latanoprost Historic Market Review by Type (2016-2021)
4.1.1 Global Latanoprost Sales Market Share by Type (2016-2021)
4.1.2 Global Latanoprost Revenue Market Share by Type (2016-2021)
4.1.3 Global Latanoprost Price by Type (2016-2021)
4.2 Global Latanoprost Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Latanoprost Sales Forecast by Type (2022-2027)
4.2.2 Global Latanoprost Revenue Forecast by Type (2022-2027)
4.2.3 Global Latanoprost Price Forecast by Type (2022-2027)
5 Global Latanoprost Market Size by Application
5.1 Global Latanoprost Historic Market Review by Application (2016-2021)
5.1.1 Global Latanoprost Sales Market Share by Application (2016-2021)
5.1.2 Global Latanoprost Revenue Market Share by Application (2016-2021)
5.1.3 Global Latanoprost Price by Application (2016-2021)
5.2 Global Latanoprost Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Latanoprost Sales Forecast by Application (2022-2027)
5.2.2 Global Latanoprost Revenue Forecast by Application (2022-2027)
5.2.3 Global Latanoprost Price Forecast by Application (2022-2027)
6 North America Latanoprost Market Facts & Figures
6.1 North America Latanoprost Sales by Company
6.1.1 North America Latanoprost Sales by Company (2016-2021)
6.1.2 North America Latanoprost Revenue by Company (2016-2021)
6.2 North America Latanoprost Sales Breakdown by Type
6.2.1 North America Latanoprost Sales Breakdown by Type (2016-2021)
6.2.2 North America Latanoprost Sales Breakdown by Type (2022-2027)
6.3 North America Latanoprost Sales Breakdown by Application
6.3.1 North America Latanoprost Sales Breakdown by Application (2016-2021)
6.3.2 North America Latanoprost Sales Breakdown by Application (2022-2027)
7 Europe Latanoprost Market Facts & Figures
7.1 Europe Latanoprost Sales by Company
7.1.1 Europe Latanoprost Sales by Company (2016-2021)
7.1.2 Europe Latanoprost Revenue by Company (2016-2021)
7.2 Europe Latanoprost Sales Breakdown by Type
7.2.1 Europe Latanoprost Sales Breakdown by Type (2016-2021)
7.2.2 Europe Latanoprost Sales Breakdown by Type (2022-2027)
7.3 Europe Latanoprost Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Latanoprost Market Facts & Figures
8.1 China Latanoprost Sales by Company
8.1.1 China Latanoprost Sales by Company (2016-2021)
8.1.2 China Latanoprost Revenue by Company (2016-2021)
8.2 China Latanoprost Sales Breakdown by Type
8.2.1 China Latanoprost Sales Breakdown by Type (2016-2021)
8.2.2 China Latanoprost Sales Breakdown by Type (2022-2027)
8.3 China Latanoprost Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Latanoprost Market Facts & Figures
9.1 Japan Latanoprost Sales by Company
9.1.1 Japan Latanoprost Sales by Company (2016-2021)
9.1.2 Japan Latanoprost Revenue by Company (2016-2021)
9.2 Japan Latanoprost Sales Breakdown by Type
9.2.1 Japan Latanoprost Sales Breakdown by Type (2016-2021)
9.2.2 Japan Latanoprost Sales Breakdown by Type (2022-2027)
9.3 Japan Latanoprost Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Latanoprost Market Facts & Figures
10.1 Southeast Asia Latanoprost Sales by Company
10.1.1 Southeast Asia Latanoprost Sales by Company (2016-2021)
10.1.2 Southeast Asia Latanoprost Revenue by Company (2016-2021)
10.2 Southeast Asia Latanoprost Sales Breakdown by Type
10.2.1 Southeast Asia Latanoprost Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Latanoprost Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Latanoprost Sales Breakdown by Application
10.3.1 Southeast Asia M Unit Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Unit Sales Breakdown by Application (2022-2027)
11 India Latanoprost Market Facts & Figures
11.1 India Latanoprost Sales by Company
11.1.1 India Latanoprost Sales by Company (2016-2021)
11.1.2 India Latanoprost Revenue by Company (2016-2021)
11.2 India Latanoprost Sales Breakdown by Type
11.2.1 India Latanoprost Sales Breakdown by Type (2016-2021)
11.2.2 India Latanoprost Sales Breakdown by Type (2022-2027)
11.3 India Latanoprost Sales Breakdown by Application
11.3.1 India Latanoprost Sales Breakdown by Application (2016-2021)
11.3.2 India Latanoprost Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Latanoprost Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Latanoprost Products Offered
12.1.5 Pfizer Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Latanoprost Products Offered
12.2.5 Mylan Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Latanoprost Products Offered
12.3.5 Novartis Recent Development
12.4 Apotex
12.4.1 Apotex Corporation Information
12.4.2 Apotex Business Overview
12.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Apotex Latanoprost Products Offered
12.4.5 Apotex Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Latanoprost Products Offered
12.5.5 Teva Recent Development
12.6 Taj Pharma
12.6.1 Taj Pharma Corporation Information
12.6.2 Taj Pharma Business Overview
12.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Taj Pharma Latanoprost Products Offered
12.6.5 Taj Pharma Recent Development
12.7 CR Zizhu
12.7.1 CR Zizhu Corporation Information
12.7.2 CR Zizhu Business Overview
12.7.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CR Zizhu Latanoprost Products Offered
12.7.5 CR Zizhu Recent Development
…
13 Latanoprost Manufacturing Cost Analysis
13.1 Latanoprost Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Latanoprost
13.4 Latanoprost Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Latanoprost Distributors List
14.3 Latanoprost Customers
15 Market Dynamics
15.1 Latanoprost Market Trends
15.2 Latanoprost Drivers
15.3 Latanoprost Market Challenges
15.4 Latanoprost Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Latanoprost Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Latanoprost Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Latanoprost Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Latanoprost Sales (M Unit) by Region (2016-2021)
Table 5. Global Latanoprost Sales Market Share by Region (2016-2021)
Table 6. Global Latanoprost Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Latanoprost Revenue Share by Region (2016-2021)
Table 8. Global Latanoprost Sales (M Unit) Forecast by Region (2022-2027)
Table 9. Global Latanoprost Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Latanoprost Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Latanoprost Revenue Share Forecast by Region (2022-2027)
Table 12. Global Latanoprost Sales (M Unit) of Key Companies (2016-2021)
Table 13. Global Latanoprost Sales Share by Company (2016-2021)
Table 14. Global Latanoprost Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Latanoprost Revenue Share by Company (2016-2021)
Table 16. Global Latanoprost by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latanoprost as of 2020)
Table 17. Global Latanoprost Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Latanoprost Manufacturing Sites and Area Served
Table 19. Manufacturers Latanoprost Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Latanoprost Sales (M Unit) by Type (2016-2021)
Table 22. Global Latanoprost Sales Share by Type (2016-2021)
Table 23. Global Latanoprost Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Latanoprost Price (USD/Unit) by Type (2016-2021)
Table 25. Global Latanoprost Sales Share by Type (2022-2027)
Table 26. Global Latanoprost Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Latanoprost Revenue Share by Type (2022-2027)
Table 28. Global Latanoprost Price (USD/Unit) by Type (2022-2027)
Table 29. Global Latanoprost Sales (M Unit) by Application (2016-2021)
Table 30. Global Latanoprost Sales Share by Application (2016-2021)
Table 31. Global Latanoprost Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Latanoprost Price (USD/Unit) by Application (2016-2021)
Table 33. Global Latanoprost Sales (M Unit) by Application (2022-2027)
Table 34. Global Latanoprost Sales Share by Application (2022-2027)
Table 35. Global Latanoprost Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Latanoprost Revenue Share by Application (2022-2027)
Table 37. Global Latanoprost Price (USD/Unit) by Application (2022-2027)
Table 38. North America Latanoprost Sales (M Unit) by Company (2016-2021)
Table 39. North America Latanoprost Sales Market Share by Company (2016-2021)
Table 40. North America Latanoprost Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Latanoprost Revenue Market Share by Company (2016-2021)
Table 42. North America Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 43. North America Latanoprost Sales Market Share by Type (2016-2021)
Table 44. North America Latanoprost Sales by Type (2022-2027) & (M Unit)
Table 45. North America Latanoprost Sales Market Share by Type (2022-2027)
Table 46. North America Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 47. North America Latanoprost Sales Market Share by Application (2016-2021)
Table 48. North America Latanoprost Sales by Application (2022-2027) & (M Unit)
Table 49. North America Latanoprost Sales Market Share by Application (2022-2027)
Table 50. Europe Latanoprost Sales (M Unit) by Company (2016-2021)
Table 51. Europe Latanoprost Sales Market Share by Company (2016-2021)
Table 52. Europe Latanoprost Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Latanoprost Revenue Market Share by Company (2016-2021)
Table 54. Europe Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 55. Europe Latanoprost Sales Market Share by Type (2016-2021)
Table 56. Europe Latanoprost Sales by Type (2022-2027) & (M Unit)
Table 57. Europe Latanoprost Sales Market Share by Type (2022-2027)
Table 58. Europe Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 59. Europe Latanoprost Sales Market Share by Application (2016-2021)
Table 60. Europe Latanoprost Sales by Application (2022-2027) & (M Unit)
Table 61. Europe Latanoprost Sales Market Share by Application (2022-2027)
Table 62. China Latanoprost Sales (M Unit) by Company (2016-2021)
Table 63. China Latanoprost Sales Market Share by Company (2016-2021)
Table 64. China Latanoprost Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Latanoprost Revenue Market Share by Company (2016-2021)
Table 66. China Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 67. China Latanoprost Sales Market Share by Type (2016-2021)
Table 68. China Latanoprost Sales by Type (2022-2027) & (M Unit)
Table 69. China Latanoprost Sales Market Share by Type (2022-2027)
Table 70. China Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 71. China Latanoprost Sales Market Share by Application (2016-2021)
Table 72. China Latanoprost Sales by Application (2022-2027) & (M Unit)
Table 73. China Latanoprost Sales Market Share by Application (2022-2027)
Table 74. Japan Latanoprost Sales (M Unit) by Company (2016-2021)
Table 75. Japan Latanoprost Sales Market Share by Company (2016-2021)
Table 76. Japan Latanoprost Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Latanoprost Revenue Market Share by Company (2016-2021)
Table 78. Japan Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 79. Japan Latanoprost Sales Market Share by Type (2016-2021)
Table 80. Japan Latanoprost Sales by Type (2022-2027) & (M Unit)
Table 81. Japan Latanoprost Sales Market Share by Type (2022-2027)
Table 82. Japan Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 83. Japan Latanoprost Sales Market Share by Application (2016-2021)
Table 84. Japan Latanoprost Sales by Application (2022-2027) & (M Unit)
Table 85. Japan Latanoprost Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Latanoprost Sales (M Unit) by Company (2016-2021)
Table 87. Southeast Asia Latanoprost Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Latanoprost Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Latanoprost Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 91. Southeast Asia Latanoprost Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Latanoprost Sales by Type (2022-2027) & (M Unit)
Table 93. Southeast Asia Latanoprost Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 95. Southeast Asia Latanoprost Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Latanoprost Sales by Application (2022-2027) & (M Unit)
Table 97. Southeast Asia Latanoprost Sales Market Share by Application (2022-2027)
Table 98. India Latanoprost Sales (M Unit) by Company (2016-2021)
Table 99. India Latanoprost Sales Market Share by Company (2016-2021)
Table 100. India Latanoprost Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Latanoprost Revenue Market Share by Company (2016-2021)
Table 102. India Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 103. India Latanoprost Sales Market Share by Type (2016-2021)
Table 104. India Latanoprost Sales by Type (2022-2027) & (M Unit)
Table 105. India Latanoprost Sales Market Share by Type (2022-2027)
Table 106. India Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 107. India Latanoprost Sales Market Share by Application (2016-2021)
Table 108. India Latanoprost Sales by Application (2022-2027) & (M Unit)
Table 109. India Latanoprost Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer Latanoprost Product
Table 114. Pfizer Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Mylan Latanoprost Product
Table 119. Mylan Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Latanoprost Product
Table 124. Novartis Recent Development
Table 125. Apotex Corporation Information
Table 126. Apotex Description and Business Overview
Table 127. Apotex Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Apotex Latanoprost Product
Table 129. Apotex Recent Development
Table 130. Teva Corporation Information
Table 131. Teva Description and Business Overview
Table 132. Teva Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Teva Latanoprost Product
Table 134. Teva Recent Development
Table 135. Taj Pharma Corporation Information
Table 136. Taj Pharma Description and Business Overview
Table 137. Taj Pharma Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Taj Pharma Latanoprost Product
Table 139. Taj Pharma Recent Development
Table 140. CR Zizhu Corporation Information
Table 141. CR Zizhu Description and Business Overview
Table 142. CR Zizhu Latanoprost Sales (M Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. CR Zizhu Latanoprost Product
Table 144. CR Zizhu Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Latanoprost Distributors List
Table 148. Latanoprost Customers List
Table 149. Latanoprost Market Trends
Table 150. Latanoprost Market Drivers
Table 151. Latanoprost Market Challenges
Table 152. Latanoprost Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Latanoprost Product Picture
Figure 2. Global Latanoprost Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Latanoprost Sales Market Share by Application in 2021 & 2027
Figure 6. Open-angle Glaucoma Examples
Figure 7. Close-angle Glaucoma Examples
Figure 8. Global Latanoprost Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Latanoprost Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Latanoprost Sales (M Unit) Growth Rate (2016-2027)
Figure 11. Global Latanoprost Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Latanoprost Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Latanoprost Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Latanoprost Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Latanoprost Sales (M Unit) Growth Rate (2016-2027)
Figure 16. Europe Latanoprost Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Latanoprost Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Latanoprost Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Latanoprost Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Latanoprost Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Latanoprost Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Latanoprost Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Latanoprost Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Latanoprost Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Latanoprost Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Latanoprost Players Market Share by Revenue in Latanoprost: 2016 & 2020
Figure 27. Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Latanoprost Revenue Share by Type (2016-2021)
Figure 29. Global Latanoprost Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Latanoprost Revenue Share by Application (2016-2021)
Figure 31. Global Latanoprost Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Latanoprost Sales Market Share by Type in 2020
Figure 33. North America Latanoprost Sales Market Share by Application in 2020
Figure 34. Europe Latanoprost Sales Market Share by Type in 2020
Figure 35. Europe Latanoprost Sales Market Share by Application in 2020
Figure 36. China Latanoprost Sales Market Share by Type in 2020
Figure 37. China Latanoprost Sales Market Share by Application in 2020
Figure 38. Japan Latanoprost Sales Market Share by Type in 2020
Figure 39. Japan Latanoprost Sales Market Share by Application in 2020
Figure 40. Southeast Asia Latanoprost Sales Market Share by Type in 2020
Figure 41. Southeast Asia Latanoprost Sales Market Share by Application in 2020
Figure 42. India Latanoprost Sales Market Share by Type in 2020
Figure 43. India Latanoprost Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Latanoprost
Figure 46. Manufacturing Process Analysis of Latanoprost
Figure 47. Latanoprost Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の開放隅角緑内障治療薬市場規模・現状・予測（2021年-2027年） Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss. The increasing demand for combination drugs will be one of the primary drivers of the open-angle glaucoma therapeutics market. Combination drugs have minimal adverse effects and help in overcoming th…- 世界のオープンアングル緑内障薬産業調査2019-2025 Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.In 2018, …
- 世界のオープンアングル緑内障薬産業調査2019-2025 Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.In 2018, …
- 世界の緑内障診断市場規模・現状・予測（2021年-2027年） Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good…
- 抗体薬物複合体（ADC）のグローバル市場2021 Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…